T lymphocytes in the synovial fluid of patients with active rheumatoid arthritis display CD134-OX40 surface antigen

Clinical and Experimental Rheumatology

Volumn 19, Issue 3, 2001, Pages 317-320

  Giacomelli, R ^a   Passacantando, A ^a   Perricone, R ^a   Parzanese, I ^a   Rascente, M ^a   Minisola, G ^a   Tonietti, G ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

CD134; Rheumatoid arthritis; TNF receptors superfamily

Indexed keywords

CD134 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; HYDROXYCHLOROQUINE; INTERLEUKIN 2 RECEPTOR; MEMBRANE ANTIGEN; METHOTREXATE; PREDNISONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; BLOOD; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; LYMPHOCYTIC INFILTRATION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVITIS; T LYMPHOCYTE; TARGET ORGAN;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD27; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD8; ANTIGENS, SURFACE; ARTHRITIS, RHEUMATOID; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; RECEPTORS, OX40; RECEPTORS, TUMOR NECROSIS FACTOR; SYNOVIAL FLUID; T-LYMPHOCYTES;

EID: 0034993132     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. T-cell-dependent pathways in rheumatoid arthritis
2. Recognition of rheumatoid arthritis synovial antigen by CD4+, CD8- T cell clones established from rheumatoid arthritis joints
3. The expanding universe of T-cell subsets: Th1, Th2 and more
4. Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis
5. Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts
6. Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax
7. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells
8. The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells
9. The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response
10. OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectors
11. Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis
12. Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAd-CAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease
13. Expression of the T-cell activation antigen. OX-40, identifies alloreactive T cells in acute graft-versus-host disease
14. Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis
15. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
16. CD134/OX40 expression by synovial fluid CD4+ T Lymphocytes in chronic synovitys
17. Molecular characterization of murine and human OX40/OX40 ligand systems: Identification of a human OX40 ligand as the HTLV-1-regulated protein gp34
18. The role of T cells in the immunopathogenesis of rheumatoid arthritis: New perspectives
19. Activation of peripheral blood T cells by interaction and migration through endothelium: Role of lymphocyte function antigen-1/intercellular adhesion molecule-1 and interleukin-15
20. Evidence for the continuous recruitment and activation of T cells into the joints of patients with rheumatoid arthritis
21. Role of cytokines in rheumatoid arthritis
22. Lymphocyte responses and cytokines review
23. Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-kappaB activation
24. OX40: Life beyond the effector T cell stage
25. The OX-40 receptor provides a potent co-stimulatory signal capable of inducing encephalitogenicity in myelin-specific CD4+ T cells
26. Gene expression (collagenase, tissue inhibitor of metalloproteinase, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intra-articular corticosteroids
27. CD4 T cell cytokine differentiation: The B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor. Blr-1
28. High levels of the soluble form of CD30 molecule in rheumatoid arthritis (RA) are expression of CD30+ T cell involvement in the inflamed joints
29. Prognostic value of Th1/Th2 ratio in rheumatoid arthritis
30. Th1/Th2 cytokine balance in arthritis
31. Soluble CD30 in early rheumatoid arthritis as a predictor of good response to second-line therapy
32. V beta CDR3 motifs associated with BP recognition are enriched in OX-40+ spinal cord T cells of Lewis rats with EAE